Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd1fd7f68037481292c9200607a05e43 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-33 |
filingDate |
1998-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53ded3149494c6f55acf29eb1145ac8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf861667c0c2ef631811d4ac271be28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4102bd9eccb9240ff9ef1793aadf0ce2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fce21cdc6b7a9404156c1023fba3801 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5be84c2cf768c9c9fadfb691a905e0b |
publicationDate |
2011-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2305303-A2 |
titleOfInvention |
Immunization against Clostridium difficile disease |
abstract |
The invention provides active and passive immunization methods for preventing and treating Clostridium difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin. C. difficile toxoids, or combinations thereof. Also provided by the invention are C. difficile toxoids. C. difficile toxin-neutralizing polyclonal immune globulin, and methods of identifying subjects that produce C. difficile toxin-neutralizing polyclonal immune globulin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013130981-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9399674-B2 |
priorityDate |
1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |